Legal battle over Novo Nordisk's semaglutide drug in India, with DRL, raises concerns over patent infringement and drug ...

Novo Nordisk has filed a lawsuit in Delhi High Court. The suit aims to stop Dr Reddy's Laboratories and OneSource from ...

Delhi High Court bars Dr Reddy's and OneSource from selling semaglutide in India, supporting Novo Nordisk's patent rights as ...

Novo Nordisk has accused Dr Reddy's and OneSource of importing semaglutide API and using it to make and export formulations.

A mother has revealed how she lost nine stone in just 12 months without resorting to weight loss jabs or surgery—instead ...

Dr. Reddy’s and OneSource agree not to sell Novo Nordisk’s anti-obesity drug in India amid patent infringement lawsuit.

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

After regaining 100 pounds following gastric sleeve surgery, the reality star turned to weight loss medication.